Author Correction: Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer

Affiliations

• ¹ Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ² Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ³ Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ⁴ Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ⁵ University of Colorado Cancer Center, Aurora, CO, USA.
• ⁶ Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
• ⁷ Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.
• ⁸ Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
• ⁹ Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
• ¹⁰ Laura & Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
• ¹¹ Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. jheymach@mdanderson.org.